Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Delayed Quote USD

BioAtla, Inc. (BCAB)

0.3460
+0.0071
+(2.10%)
At close: April 22 at 4:00:01 PM EDT
0.3666
+0.02
+(5.95%)
After hours: April 22 at 7:21:26 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,000
11,000
--
--
250
Operating Expense
84,943
84,943
129,687
108,140
96,690
Operating Income
-73,943
-73,943
-129,687
-108,140
-96,440
Net Non Operating Interest Income Expense
3,369
3,369
6,312
1,648
347
Other Income Expense
798
798
-87
10
691
Pretax Income
-69,776
-69,776
-123,462
-106,482
-95,402
Net Income Common Stockholders
-69,776
-69,776
-123,462
-106,482
-95,402
Diluted NI Available to Com Stockholders
-69,776
-69,776
-123,462
-106,482
-95,402
Basic EPS
-1.70
-1.44
-2.58
-2.24
-2.76
Diluted EPS
-1.70
-1.44
-2.58
-2.24
-2.76
Basic Average Shares
48,157.0110
48,573.3640
47,777.5680
47,548.1250
34,561.2450
Diluted Average Shares
48,157.0110
48,573.3640
47,777.5680
47,548.1250
34,561.2450
Total Operating Income as Reported
-73,943
-73,943
-129,687
-108,140
-96,440
Total Expenses
84,943
84,943
129,687
108,140
96,690
Net Income from Continuing & Discontinued Operation
-69,776
-69,776
-123,462
-106,482
-95,402
Normalized Income
-70,583
-70,583
-123,462
-106,482
-96,092
Interest Income
3,369
3,369
6,312
1,648
350
Interest Expense
--
--
--
--
3
Net Interest Income
3,369
3,369
6,312
1,648
347
EBIT
-73,943
-73,943
-129,687
-108,140
-95,399
EBITDA
-73,018
-73,018
-128,466
-106,941
-94,069
Reconciled Depreciation
925
925
1,221
1,199
1,330
Net Income from Continuing Operation Net Minority Interest
-69,776
-69,776
-123,462
-106,482
-95,402
Total Unusual Items Excluding Goodwill
807
807
--
--
690
Total Unusual Items
807
807
--
--
690
Normalized EBITDA
-73,825
-73,825
-128,466
-106,941
-94,759
12/31/2021 - 12/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VOR Vor Biopharma Inc.
0.7020
+2.27%
 
CGEM Cullinan Therapeutics, Inc.
8.37
+3.33%
 
IGMS IGM Biosciences, Inc.
1.4600
+14.06%
 
XNCR Xencor, Inc.
10.65
+0.47%
 
STRO Sutro Biopharma, Inc.
0.7248
+31.23%
 
ADCT ADC Therapeutics SA
1.2300
0.00%
 
VTYX Ventyx Biosciences, Inc.
1.1800
+4.42%
 
LCTX Lineage Cell Therapeutics, Inc.
0.4298
+7.45%
 
NRIX Nurix Therapeutics, Inc.
11.46
+8.63%
 
ZYME Zymeworks Inc.
12.16
+3.49%